Trademark Overview
On Friday, February 7, 2025, a trademark application was filed for XINTELA with the United States Patent and Trademark Office. The USPTO has given the XINTELA trademark a serial number of 79419826. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 20, 2025. This trademark is owned by Xintela AB. The XINTELA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Stem cells for medical and veterinary purposes; DNA and RNA for medical and veterinary purposes; surgical implants comprised of living tissues, namely, stem cells grown from stem cells; antibodies for medical purposes; biological preparations for the treatment of malignant tumors, biological preparations for use as marker or target of all kinds of cells for therapeutic or diagnostic use and for use as marker or target in different physiological or therapeutic methods for therapeutic or diagnostic use; kit consisting of stem cells, antibodies and proteins for medical and veterinary purposes; all of the foregoing excluding pharmaceutical preparations for use in the treatment and/or management of sleep disorders
Stem cells for research and scientific purposes; antibodies for research and industrial purposes; DNA and RNA for scientific and industrial purposes; proteins for use within science; kit consisting of stem cells, antibodies and proteins for scientific and industrial purposes
Scientific research services; laboratory research services in the field of medicine, chemistry, stem cells, DNA, RNA, antibodies and proteins; quality control for others